In this episode of Annals On Call, @medrants discusses the association between gabapentinoids and #COPD with @AlviRahman_ and Dr. Christel Renoux: https://t.co/9LCrBpXu9l
Happy to share our article recently published in @AnnalsofIM! We reported an increased risk of hospitalization for COPD exacerbation associated with gabapentinoids, supporting recent warnings from public health agencies. Many thanks to our research team!
https://t.co/5KJxALFTuD
Happy to have discussed my thesis research with the Video Journal of Neurology! Check out this quick 4 min video if interested :)
https://t.co/G5vBwKblyJ
In our latest paper, published Neurology @GreenJournal, oral anticoagulants were associated with a reduced risk of dementia in patients with non-valvular AF. A strategy to address the growing burden of dementia? Big thanks to Dr. Christel Renoux & team!
https://t.co/xdSLj94mMd
Pleased to share the first part of my thesis, published in @TH_Journal. Our systematic review and meta-analysis showed a 35% increased risk of major bleeding associated with the concomitant use of SSRIs and OACs. Big thank you to everyone involved for their support! #McGillRxEpi
Lundi 13 sept. Un plaisir d’écouter pour la réunion service Pharmacologie du @CHUdeToulouse l’équipe de pharmaco-epi de l’université de @mcgillu 🇨🇦 pour parler évaluation des interactions médicamenteuses Super présentation 👏🏻 @AlviRahman_ avec Pr Renoux
Join the #DDI Spotlight Poster Session today at 5:15-6:30, where I will be presenting on the association between the risk of major bleeding and the concomitant use of SSRIs and oral anticoagulants! #ICPE2021
Our paper published in @BritJClinPharm studies trends in new gabapentinoid Rx and opioid co-Rx across the UK nations. Rate of new pregabalin precriptions was up to 5 times greater in N. Ireland than other nations. Thank you Dr. Christel Renoux and team.
https://t.co/oB1yLklU46